Related Experiment Video
Updated: Oct 8, 2025
08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
11.5K
FSHR antagonists can trigger a PCOS-like state.
Faiza Hanif Waghu1, Karishma Desai2, Sumana Srinivasan1
1Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, India.
Systems Biology in Reproductive Medicine
|December 30, 2021
Summary
Follicle-stimulating hormone receptor (FSHR) antagonists may induce a Polycystic Ovarian Syndrome (PCOS)-like state. This study validated the hypothesis using gene expression and theoretical simulations, revealing typical PCOS characteristics.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
- Genetics
Background:
- Follicle-stimulating hormone receptor (FSHR) is a key target for fertility regulation agents.
- FSHR antagonism can lead to subfertility or infertility.
- Previous studies identified an FSHR antagonist peptide (FSHβ (89-97)) that induced PCOS-like symptoms.
Purpose of the Study:
- To validate the hypothesis that FSHR antagonists can trigger a Polycystic Ovarian Syndrome (PCOS)-like state.
- To investigate the molecular and physiological effects of FSHR antagonism in the context of PCOS.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) validation of gene expression in ovarian tissue samples.
- Evaluation of genes known to be differentially expressed in PCOS.
- Theoretical simulations using a human menstrual cycle model to assess FSHR antagonism effects.
Main Results:
- Gene expression analysis showed patterns similar to the PCOS state.
- Model simulations indicated increased testosterone levels and an elevated LH/FSH ratio.
- Simulations also revealed stockpiling of secondary follicles, a hallmark of PCOS.
Conclusions:
- FSHR antagonists show potential to induce a PCOS-like condition.
- Findings are relevant for evaluating FSHR antagonists in fertility regulation and reproductive medicine.
- Further research is warranted to understand the full implications of FSHR antagonism.
Related Concept Videos
01:30Hormonal Control of the Ovarian Cycle
4.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
4.1K
01:24Disorders of the Female Reproductive System
1.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
1.7K
01:22Hormonal Regulation of the Menstrual Cycle
783
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
783
01:22Target Cell Response to Hormones
3.7K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.7K
01:27Ovarian Cycle
2.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
2.1K
01:09GPCRs Regulate Adenylyl Cylase Activity
6.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.1K